ALAUNOS THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$1.95
+3.17%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+112.0%
3 months
+2.4%
6 months
-25.3%
1 year
-27.2%
Year to date
-39.6%
52-week range
$0.74 – $4.36
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$5M
P/E
-1.2
P/B
7.7
P/S
1,666.7
Revenue
$3K
Net income
-$4.01M
Diluted EPS
-1.91
Gross margin
100.00%
Net margin
-133666.70%
Return on equity
-232.60%
Total debt
$0
Cash
$124K
Free cash flow
-$2.73M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$952K | — | — | -$300K |
| Mar 31, 2026 | $0 | -$1.01M | — | — | -$1.03M |
| Dec 31, 2025 | $3K | -$893K | 100.00% | -29766.70% | -$553K |
| Sep 30, 2025 | $0 | -$1.16M | — | — | -$844K |
| Jun 30, 2025 | $0 | -$1.05M | — | — | -$701K |
| Mar 31, 2025 | $0 | -$1.07M | — | — | -$772K |
| Dec 31, 2024 | $4K | -$742K | 100.00% | -18550.00% | -$592K |
| Sep 30, 2024 | $0 | -$1.13M | — | — | -$781K |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent TCRT news
All market newsNo ticker-linked stories are in the current archive.